IDEA enters new era as the leading association for health, wellness and fitness professionals. SAN DIEGO, May 19, 2022 /PRNewswire/ -- IDEA Health & Fitness Association, the world's leading...

Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery,...

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive...

The first and only festival of its kind celebrating birth workers, caregivers and families. Health experts, policy leaders, and community members will center maternal and reproductive health, and...

- Oral presentation of new preclinical data at American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting - SAN DIEGO, May 19, 2022 /PRNewswire/ -- Locanabio, Inc., a genetic medicines...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and...

4C Medical Technologies, Inc. ("4C Medical" or the "Company"), a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease,...

Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Global Healthcare Conference in New York, on Tuesday, May 24, 2022, which includes a presentation...

Dr. Wolf Ruprecht Wiedemeyer to present at two seminars, Discovery and Development of Novel Covalent TEAD Inhibitors; and Leveraging the Hippo Pathway for Therapeutics Intervention – Optimizing...

Company to Present Corporate Update During Investor Webcast, May 24, 2022, at 7:00am ET RADNOR, Pa., May 19, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage...